Professionals >

Contacts >

Representative Engagements >

The ongoing biotechnology revolution affects all aspects of our lives: the way we live, the foods we eat, and the way we care for our health and our environment. Despite the benefits they deliver, life sciences and pharmaceuticals companies, researchers, and educational institutions operate in one of the most highly regulated and contentious areas of commerce.

The experienced life sciences team at Crowell & Moring helps businesses and individuals explore and exploit new opportunities and markets for their products and ideas, ensure compliance with international and national regulatory requirements, and resolve disputes through litigation, mediation, and settlement. Our clients include individual inventors, research labs, privately owned start-ups, small to large biotech product and platform companies, and multinational pharmaceutical, bioagricultural, and chemical companies.

We provide full-spectrum legal counsel in the following areas:

Business Formation, Corporate Transactions and Finance

Crowell & Moring represents clients in a variety of corporate securities and business transactions, including business formation, debt and equity financing, cross-border transactions, initial public offerings, mergers and acquisitions, joint ventures, tax, divestitures, domestic and global distribution agreements, scientific research funding arrangements, and wholesaler joint ventures and marketing arrangements.

Intellectual Property

Our lawyers have excellent technical and legal credentials and, in many cases, invaluable industry experience in the life sciences, chemistry, and biotechnology spaces. Crowell & Moring meets the diverse needs of clients in the life sciences industry by drawing from a wealth of intellectual property and information technology experience. Our lawyers have excellent technical and legal credentials and, in many cases, have worked directly in the life sciences, chemistry, and biotechnology spaces. Our services encompass everything from providing guidance in the development, protection, and monetization of assets to enforcing and defending clients’ IP rights.

Regulatory and Fraud and Abuse Compliance

We advise clients on a variety of regulatory and fraud and abuse issues, including Medicaid "best price" and other statutory pricing requirements, federal and state anti-kickback and consumer protection laws, development and implementation of formularies, legal risks associated with potential conflicts of interest in business relationships, and DEA investigations of pharmacy drug handling and recordkeeping. Our lawyers also develop compliance programs and policies, and regularly conduct internal investigations and compliance reviews.


Crowell & Moring's renowned antitrust team handles a broad range of antitrust and trade regulation litigation and counseling matters. We regularly advise clients on mergers and acquisitions, joint ventures, licensing arrangements, brand-generic competition restraints, price discrimination issues, distribution-related challenges, unfair competition claims, and exclusion of pharmacy chains from managed care networks.

Government Contracts

Crowell & Moring has counseled pharmaceutical manufacturers, medical technology and equipment manufacturers, and prescription benefit managers on Veterans Administration and General Services Administration procurements, Federal Supply Service defective pricing issues, Federal Employees Health Benefit Program requirements, issues related to Medicaid rebates, and matters related to the Multiple Award Schedule.

Litigation and Government Investigations

Crowell & Moring lawyers have represented clients in a broad range of commercial and criminal litigation, including federal antitrust litigation and unfair trade practice investigations, as well as enforcement actions by state and federal regulators. We have successfully represented businesses in antitrust litigation challenging allegedly discriminatory pharmaceutical pricing, fraud and abuse investigations involving rebate arrangements, SEC investigations, and Superfund and environmental crimes litigation and investigations.

Torts/Product Liability Prevention and Counseling

Crowell & Moring's mass tort, product, and consumer litigation practice spans the full gamut of capabilities, including class actions, multidistrict proceedings, and national and regional coordination of litigation. Our lawyers have litigated high profile and complex cases involving pharmaceuticals, medical devices, and toxic substances. Our substantial product litigation experience positions us well to help our clients avoid litigation. We advise clients on matters involving product safety, including risk management advice and counseling; product labeling issues including indications for use and warnings; and products investigations, addressing defects, and handling recalls.

International Law and Regulation

Crowell & Moring's U.S., London and Brussels office lawyers advise pharmaceutical and life sciences industry clients on the application and interpretation of EU directives and regulatory matters concerning marketed products, including labeling and advertising, import and export controls, preparation and negotiation of research, development, licensing, and manufacturing agreements for corporate and commercial transactions, licensing of medical products, and antitrust and competition matters. Through our affiliate C&M International, we also works with clients to develop positive life sciences initiatives and manage risk in a variety of international fora, including the World Trade Organization, the Organization for Economic Cooperation and Development, the Asia-Pacific Economic Cooperation forum, and the U.N. negotiations on the Biosafety Protocol.

View More

"President Biden Signs American Rescue Plan Act of 2021, sets in motion historic expansions of the ACA, Medicaid and other important health policy related changes among sweeping pandemic relief provisions," Administrative Law Alert (March 12, 2021). Contacts: Troy A. Barsky, James G. Flood, Christopher Flynn, Paul Mourning, Roma Sharma, W. Scott Douglas, Stacie Heller, Tim Shadyac
Client Alert/Newsletter
"FDA Postpones DSCSA Provision Enforcement by Three Years," Mass Tort, Product, and Consumer Litigation Alert (November 5, 2020). Contacts: John Fuson, Andrew D. Kaplan, Luke Bresnahan
Client Alert/Newsletter
The Best Lawyers in America 2021 Recognizes 46 Crowell & Moring Attorneys, Two Selected as Lawyer of the Year (Aug.20.2020)
Firm News/Announcement
"The Patent Prosecution Lifecycle," Pennsylvania Biotechnology Center, Doylestown, PA (February 26, 2020). Speakers: Terry Rea and Mena Gaballah, PharmD.
LITIGATION NOTE: Crowell & Moring Client Agilent Successfully Rebuts Preliminary Injunction Because Patent Likely Invalid (Oct.04.2019)
Firm News/Announcement
The Best Lawyers in America 2020 Recognizes 49 Crowell & Moring Attorneys, Three Selected as Lawyer of the Year (Aug.16.2019)
Firm News/Announcement
"Fireside Chat: An Interview With: Stacy Amin," ACI's Women Leaders in Life Sciences Law, Boston, MA (July 25, 2019). Interviewer: Terry Rea.
"Introduction to FDA Review and Approval of Drugs & Biologics," Introduction to Drug, Biologics, and Biosimilars Law and Regulation, Boston, MA (July 23, 2019). Presenter: Terry Rea.
Legal 500 EMEA Recommends Crowell & Moring in 11 Practice Areas and Recognizes 14 Lawyers (Apr.16.2019)
Firm News/Announcement
"Concurrent Session 1A Recent Developments: Biosimilar Challengers in PTAB Proceedings," 2019 PTAB Bar Association Annual Conference, Washington, D.C. (March 14, 2019). Presenter: Terry Rea.

To view more News & Events for this area, please go to our desktop site.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2021
Attorney advertising - prior results do not guarantee a similar outcome.